Seeking Alpha

Aegerion (AEGR +6.6%) continues its uptrend, with the stock close to breaking out of a trading...

Aegerion (AEGR +6.6%) continues its uptrend, with the stock close to breaking out of a trading range that has persisted since 2011. The stock popped yesterday in reaction to an FDA staff report on its cholesterol drug lomitapide, and has ramped up nearly 35% since Friday in anticipation of its release.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector